QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)

Carmell (CTCX) Competitors

$3.22
+0.05 (+1.58%)
(As of 02/28/2024 ET)

CTCX vs. XAIR, NVNO, DRIO, ICU, SRTS, ICCM, PDEX, LUCD, APYX, and NSPR

Should you be buying Carmell stock or one of its competitors? The main competitors of Carmell include Beyond Air (XAIR), enVVeno Medical (NVNO), DarioHealth (DRIO), SeaStar Medical (ICU), Sensus Healthcare (SRTS), IceCure Medical (ICCM), Pro-Dex (PDEX), Lucid Diagnostics (LUCD), Apyx Medical (APYX), and InspireMD (NSPR). These companies are all part of the "surgical & medical instruments" industry.

Carmell vs.

Beyond Air (NASDAQ:XAIR) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership, community ranking and risk.

Carmell has lower revenue, but higher earnings than Beyond Air.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beyond Air$870K84.92-$55.82M-$2.13-0.96
CarmellN/AN/A$200KN/AN/A

Beyond Air received 43 more outperform votes than Carmell when rated by MarketBeat users.

CompanyUnderperformOutperform
Beyond AirOutperform Votes
43
68.25%
Underperform Votes
20
31.75%
CarmellN/AN/A

Beyond Air has a beta of -0.23, suggesting that its stock price is 123% less volatile than the S&P 500. Comparatively, Carmell has a beta of 0.4, suggesting that its stock price is 60% less volatile than the S&P 500.

30.6% of Beyond Air shares are owned by institutional investors. Comparatively, 67.2% of Carmell shares are owned by institutional investors. 19.0% of Beyond Air shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Carmell had 3 more articles in the media than Beyond Air. MarketBeat recorded 5 mentions for Carmell and 2 mentions for Beyond Air. Carmell's average media sentiment score of 1.47 beat Beyond Air's score of 0.31 indicating that Beyond Air is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Beyond Air
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Carmell
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Beyond Air presently has a consensus target price of $11.25, suggesting a potential upside of 448.78%. Given Carmell's higher possible upside, equities research analysts plainly believe Beyond Air is more favorable than Carmell.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beyond Air
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Carmell
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Beyond Air's return on equity of -122.39% beat Carmell's return on equity.

Company Net Margins Return on Equity Return on Assets
Beyond AirN/A -199.90% -106.00%
Carmell N/A -122.39%-2.45%

Summary

Beyond Air and Carmell tied by winning 6 of the 12 factors compared between the two stocks.


Get Carmell News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTCX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTCX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTCX vs. The Competition

MetricCarmellSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$61.95M$3.71B$4.98B$7.46B
Dividend YieldN/A2.16%2.90%3.88%
P/E RatioN/A19.86260.3018.41
Price / SalesN/A27.723,085.5364.70
Price / Cash247.7625.6095.4054.69
Price / Book-10.394.024.464.67
Net Income$200,000.00$8.46M$113.20M$210.96M
7 Day Performance4.55%1.66%5.08%2.50%
1 Month Performance-5.57%50.15%13.05%4.82%
1 Year PerformanceN/A2.50%11.95%7.46%

Carmell Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XAIR
Beyond Air
4.0597 of 5 stars
$1.94
-5.4%
$11.25
+479.9%
-67.8%$69.92M$870,000.00-0.9198
NVNO
enVVeno Medical
0.4678 of 5 stars
$5.02
+2.4%
N/A+6.3%$66.87MN/A0.0019News Coverage
Positive News
Gap Down
DRIO
DarioHealth
1.9205 of 5 stars
$2.35
-7.8%
$6.03
+156.7%
-52.0%$63.97M$27.66M-2.08241Short Interest ↑
News Coverage
Positive News
ICU
SeaStar Medical
2.8265 of 5 stars
$1.16
+24.7%
$5.00
+331.0%
-74.3%$63.94MN/A0.009Short Interest ↑
News Coverage
High Trading Volume
SRTS
Sensus Healthcare
2.3826 of 5 stars
$4.71
+16.3%
$7.50
+59.2%
-34.2%$77.15M$24.41M157.0542Short Interest ↑
High Trading Volume
ICCM
IceCure Medical
2.0207 of 5 stars
$1.37
-2.1%
$3.50
+155.5%
+18.8%$62.50M$3.09M-3.7065Short Interest ↑
Gap Down
PDEX
Pro-Dex
0 of 5 stars
$17.66
-3.7%
N/A+7.7%$61.99M$46.09M23.55145News Coverage
LUCD
Lucid Diagnostics
1.8085 of 5 stars
$1.36
-0.7%
$3.25
+139.0%
-5.9%$60.75M$380,000.00-1.052,021Short Interest ↑
Negative News
High Trading Volume
APYX
Apyx Medical
3.5726 of 5 stars
$2.32
+8.4%
$6.17
+165.8%
-26.6%$80.37M$44.51M-5.40276Positive News
NSPR
InspireMD
1.9029 of 5 stars
$2.64
-1.9%
$4.85
+83.7%
+137.4%$56.89M$5.17M-1.7455Analyst Report
News Coverage
Gap Up

Related Companies and Tools

This page (NASDAQ:CTCX) was last updated on 2/28/2024 by MarketBeat.com Staff